iBio Inc.

iBio Technology

iBio Technology is a Transformative Patented Technology for Biotherapeutics and Vaccines

View iBio Technology

Product Pipeline


iBio is developing a proprietary therapeutic product for the treatment of idiopathic pulmonary fibrosis (IPF), systemic scleroderma and other fibrotic diseases

Phase completed
not started
not started
not started
not started
not started
Preclinical Phase 1 Phase 2a Phase 2b Phase 3 Market


Biotechnology and pharmaceutical companies are currently out-licensing the iBio Technology platform, among other collaborative efforts.

View Partners

About iBio

iBio, Inc., a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.

More About iBio

Investor Relations

iBio Inc. NYSE American: IBIO Loading...
Volume Loading...
Day Low/High Loading...
52 Wk Range Loading...